Literature DB >> 34140109

Systematic Coronary Risk Evaluation (SCORE): JACC Focus Seminar 4/8.

Ian M Graham1, Emanuele Di Angelantonio2, Frank Visseren3, Dirk De Bacquer4, Brian A Ference2, Adam Timmis5, Martin Halle6, Panos Vardas7, Radu Huculeci8, Marie-Therese Cooney9.   

Abstract

Clinical estimation of the combined effect of several risk factors is unreliable and this resulted in the development of a number of risk estimation systems to guide clinical practice. Here, after defining general principles of risk estimation, the authors describe the evolution of the European Society of Cardiology's (ESC) Systematic COronary Risk Evaluation (SCORE) risk estimation system and some learnings from the data. They move on to describe the establishment of the ESC's Cardiovascular Risk Collaboration and outline its proposed research directions. First among these is the evolution of SCORE 2, which provides updated, calibrated risk estimates for total cardiovascular events for low, moderate, high, and very high-risk regions of Europe. The authors conclude by considering that the future of risk estimation may be to express risk as years of exposure to a cardiovascular risk factor profile rather than risk over a fixed time period, such as 10 years, and how advances in genetics may permit individualized lifetime risk estimation from childhood on.
Copyright © 2021 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CVD risk assessment; Heart Score; cardiovascular disease; prevention; risk assessment

Year:  2021        PMID: 34140109     DOI: 10.1016/j.jacc.2021.04.052

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  1 in total

1.  Risk Factors for Locomotive Crew Members Depending on Their Place of Work.

Authors:  Elena A Zhidkova; Ekaterina M Gutor; Inga A Popova; Victoria A Zaborova; Kira Kryuchkova; Konstantin G Gurevich; Natella I Krikheli; Katie M Heinrich
Journal:  Int J Environ Res Public Health       Date:  2022-06-16       Impact factor: 4.614

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.